Full View

BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups

ML Berres, KPH Lim, T Peters, J Price… - Journal of Experimental …, 2014 - rupress.org
Langerhans cell histiocytosis (LCH) is a clonal disorder with elusive etiology, characterized
by the accumulation of CD207+ dendritic cells (DCs) in inflammatory lesions. Recurrent …
被引用次数：455 相关文章

BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.

ML Berres, KP Lim, T Peters, J Price… - The Journal of …, 2014 - europepmc.org
Langerhans cell histiocytosis (LCH) is a clonal disorder with elusive etiology, characterized
by the accumulation of CD207+ dendritic cells (DCs) in inflammatory lesions. Recurrent …
[PDF] scienceopen.com

[PDF][PDF] BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups

ML Berres, KPH Lim, T Peters, A Ruzo, PJ Lupo… - J. Exp …, 2014 - scienceopen.com
Langerhans cell histiocytosis (LCH) is a clonal disorder with elusive etiology, characterized
by the accumulation of CD207+ dendritic cells (DCs) in inflammatory lesions. Recurrent …

BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups

ML Berres, KPH Lim, T Peters, J Price… - Journal of Experimental …, 2014 - sonar.ch
English Langerhans cell histiocytosis (LCH) is a clonal disorder with elusive etiology,
characterized by the accumulation of CD207+ dendritic cells (DCs) in inflammatory lesions …

BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups

ML Berres, KPH Lim, T Peters, J Price… - Journal of Experimental …, 2014 - zora.uzh.ch
Langerhans cell histiocytosis (LCH) is a clonal disorder with elusive etiology, characterized
by the accumulation of CD207 (+) dendritic cells (DCs) in inflammatory lesions. Recurrent …
[PDF] semanticscholar.org

[PDF][PDF] BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups

ML Berres, KP Lim, T Peters, J Price… - Journal of …, 2014 - pdfs.semanticscholar.org
Langerhans cell histiocytosis (LCH) is a clonal disorder with elusive etiology, characterized
by the accumulation of CD207 (+) dendritic cells (DCs) in inflammatory lesions. Recurrent …
[PDF] academia.edu

[PDF][PDF] BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups

ML Berres, KPH Lim, T Peters, A Ruzo, PJ Lupo… - J. Exp. Med, 2014 - academia.edu
Langerhans cell histiocytosis (LCH) is a clonal disorder with elusive etiology, characterized
by the accumulation of CD207+ dendritic cells (DCs) in inflammatory lesions. Recurrent …

BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups

ML Berres, KPH Lim, T Peters… - The Journal of …, 2014 - pubmed.ncbi.nlm.nih.gov
Langerhans cell histiocytosis (LCH) is a clonal disorder with elusive etiology, characterized
by the accumulation of CD207 (+) dendritic cells (DCs) in inflammatory lesions. Recurrent …

BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups

ML Berres, KPH Lim, T Peters, J Price… - Journal of …, 2014 - folia.unifr.ch
English Langerhans cell histiocytosis (LCH) is a clonal disorder with elusive etiology,
characterized by the accumulation of CD207+ dendritic cells (DCs) in inflammatory lesions …

BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups

ML Berres, KPH Lim, T Peters, J Price… - Journal of …, 2014 - eprints.ncl.ac.uk
Langerhans cell histiocytosis (LCH) is a clonal disorder with elusive etiology, characterized
by the accumulation of CD207 (+) dendritic cells (DCs) in inflammatory lesions. Recurrent …